Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$10.01 - $13.86 $1.48 Million - $2.05 Million
147,845 New
147,845 $1.71 Million
Q1 2022

May 16, 2022

SELL
$28.1 - $35.25 $541,065 - $678,738
-19,255 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $30,460 - $45,188
1,027 Added 5.63%
19,255 $654,000
Q3 2021

Nov 15, 2021

BUY
$43.09 - $82.26 $156,976 - $299,673
3,643 Added 24.98%
18,228 $785,000
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $758,857 - $1 Million
14,585 New
14,585 $950,000
Q1 2019

May 14, 2019

SELL
$90.12 - $152.23 $274,866 - $464,301
-3,050 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$112.83 - $239.74 $62,394 - $132,576
-553 Reduced 15.35%
3,050 $378,000
Q3 2018

Nov 15, 2018

BUY
$189.1 - $282.92 $681,327 - $1.02 Million
3,603 New
3,603 $879,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $189M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.